Patents Assigned to Mauha Corporation
  • Methods and kits for detecting or predicting ischemic disorders
    Patent number: 6461827
    Abstract: The present invention provides a method for detecting or predicting ischemic disorders in a subject by using as an indication the concentration of human lipocalin-type prostaglandin D synthase (hPGDS) in body fluid samples from the subject. More specifically, the method comprises comparing the hPGDS concentrations in the body fluid samples from a subject with the reference values established for a normal subject, thereby detecting or predicting the ischemic disorders.
    Type: Grant
    Filed: October 29, 1999
    Date of Patent: October 8, 2002
    Assignees: Mauha Corporation, Osaka Bioscience Institute
    Inventors: Hiroshi Oda, Nobuyuki Sato, Masazumi Nishikawa, Kosuke Seiki, Yoshihiro Urade, Yutaka Eguchi, Naomi Eguchi